BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

BRL 17421 is a new semisynthetic beta-lactam antibiotic with an unusual spectrum of antibacterial activity. The compound exhibits exceptional stability to a wide range of bacterial beta-lactamases and is active against the majority of Enterobacteriaceae, including strains highly resistant to many of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Slocombe, B, Basker, M J, Bentley, P H, Clayton, J P, Cole, M, Comber, K R, Dixon, R A, Edmondson, R A, Jackson, D, Merrikin, D J, Sutherland, R
Formato: Artigo
Idioma:Inglês
Publicado em: 1981
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC181629/
https://ncbi.nlm.nih.gov/pubmed/6974539
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados